Publications by authors named "Mark A Tepper"

Claim this Profile
A
A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders.
Randall D Marshall, Frank S Menniti, Mark A Tepper

Cells· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.
Abdullah A Tarique, Tama Evron, George Zhang, Mark A Tepper, Mohammed M Morshed

J Cyst Fibros· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
Mark A Tepper, Robert B Zurier, Sumner H Burstein

Bioorg Med Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist.
Sumner H Burstein, Mark A Tepper

Pharmacol Res Perspect· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice.
Sean D McKenna, Kristin Vergilis, Antonio R N Arulanandam, Weishui Y Weiser, Roustem Nabioullin, Mark A Tepper

J Interferon Cytokine Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis